AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$1.21B |
| 2 |
Advanced Micro Devices
AMD
|
+$1.15B |
| 3 |
Quanta Services
PWR
|
+$691M |
| 4 |
Trane Technologies
TT
|
+$684M |
| 5 |
RTX Corp
RTX
|
+$655M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.74B |
| 2 |
Microsoft
MSFT
|
+$2.35B |
| 3 |
Broadcom
AVGO
|
+$744M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$636M |
| 5 |
TSMC
TSM
|
+$590M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.92% |
| 2 | Miscellaneous | 10.92% |
| 3 | Healthcare | 10.85% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Financials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Lakeland Financial Corp
LKFN
$1.51B
| $1.46M | ﹤0.01% |
25,377
-1,540
| -6% | -$92.8K |
|
2202
Amylyx Pharmaceuticals
AMLX
$3.8B
| $1.45M | ﹤0.01% |
104,400
+23,600
| +29% | +$365K |
|
2203
Enovis
ENOV
$1.07B
| $1.45M | ﹤0.01% |
63,771
| – | – |
|
2204
Recursion Pharmaceuticals
RXRX
$1.95B
| $1.45M | ﹤0.01% |
472,284
+14,780
| +3% | +$49.2K |
|
2205
TFS Financial
TFSL
$4.93B
| $1.45M | ﹤0.01% |
103,170
-20,909
| -17% | -$326K |
|
|
DMRA
2206
Damora Therapeutics
DMRA
$1.86B
| $1.45M | ﹤0.01% |
+55,710
| New | +$1.35M |
|
|
CAI
2207
Caris Life Sciences
CAI
$7.08B
| $1.45M | ﹤0.01% |
81,021
+23,945
| +42% | +$429K |
|
|
HOS
2208
Hornbeck Offshore Services, Inc.
HOS
$1.36B
| $1.45M | ﹤0.01% |
146,330
+14,900
| +11% | +$143K |
|
|
GLIBK
2209
Liberty Capital Corp Series C GCI Group Common Stock
GLIBK
$1.05B
| $1.45M | ﹤0.01% |
38,890
+25,900
| +199% | +$727K |
|
2210
Columbia Sportswear
COLM
$2.95B
| $1.45M | ﹤0.01% |
26,392
-48,800
| -65% | -$3.02M |
|
2211
Deluxe
DLX
$1.11B
| $1.44M | ﹤0.01% |
52,354
+10,360
| +25% | +$270K |
|
2212
Monte Rosa Therapeutics
GLUE
$1.18B
| $1.44M | ﹤0.01% |
87,420
+31,720
| +57% | +$599K |
|
2213
AdaptHealth
AHCO
$866M
| $1.44M | ﹤0.01% |
120,769
| – | – |
|
2214
Peoples Bancorp
PEBO
$1.44B
| $1.43M | ﹤0.01% |
43,649
+9,850
| +29% | +$343K |
|
2215
Nathan's Famous
NATH
$404M
| $1.43M | ﹤0.01% |
14,240
+300
| +2% | +$30.4K |
|
2216
Napco Security Technologies
NSSC
$1.32B
| $1.43M | ﹤0.01% |
36,250
-1,392
| -4% | -$55.3K |
|
2217
Sony
SONY
$143B
| $1.42M | ﹤0.01% |
68,827
+6,521
| +10% | +$137K |
|
|
AAT
2218
American Assets Trust
AAT
$1.35B
| $1.42M | ﹤0.01% |
77,235
-3,572
| -4% | -$78.4K |
|
2219
REX American Resources
REX
$1.38B
| $1.42M | ﹤0.01% |
31,100
-1,100
| -3% | -$50.9K |
|
2220
Gorman-Rupp
GRC
$1.99B
| $1.42M | ﹤0.01% |
22,797
-1,574
| -6% | -$120K |
|
2221
Safety Insurance
SAFT
$1.51B
| $1.41M | ﹤0.01% |
19,454
| – | – |
|
2222
Tompkins Financial
TMP
$1.43B
| $1.41M | ﹤0.01% |
17,860
| – | – |
|
2223
XPEL
XPEL
$1.42B
| $1.41M | ﹤0.01% |
31,748
+8,420
| +36% | +$384K |
|
2224
La-Z-Boy
LZB
$1.31B
| $1.4M | ﹤0.01% |
43,586
-1,100
| -2% | -$39.8K |
|
2225
Zymeworks
ZYME
$2.09B
| $1.4M | ﹤0.01% |
55,896
| – | – |
|
Similar funds
AllianceBernstein's Q2 2026 Portfolio in Review
As of Q2 2026, AllianceBernstein held 3,456 positions worth $302B, down 2.1% from $309B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
AllianceBernstein withdrew a net $10.1B in Q2 2026, closing 139 positions and reducing 1,179 holdings. Its most notable exit was Hologic, an estimated $75.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Miscellaneous and Healthcare.
Against the trend, AllianceBernstein opened a new position in Honeywell Aerospace worth $183M.
- AllianceBernstein's largest Q2 2026 buy was Honeywell Aerospace: 827,059 shares worth $183M.
- AllianceBernstein added most to Micron Technology in Q2 2026, an estimated $1.21B increase.
- AllianceBernstein's biggest Q2 2026 reduction was Amazon, cutting an estimated $3.74B.
- AllianceBernstein fully exited Hologic in Q2 2026, selling an estimated $75.9M.
- AllianceBernstein's ten largest holdings make up 31% of its $302B portfolio in Q2 2026.
- AllianceBernstein opened 228 new positions and closed 139 in Q2 2026.
- AllianceBernstein's portfolio value fell 2.1% quarter-over-quarter to $302B.
Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.